A detailed history of Brewin Dolphin LTD transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Brewin Dolphin LTD holds 1,981 shares of TEVA stock, worth $34,667. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,981
Previous 1,981 -0.0%
Holding current value
$34,667
Previous $19,000 21.05%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Nov 14, 2022

BUY
$7.9 - $10.19 $15,649 - $20,186
1,981 New
1,981 $16,000
Q2 2021

Nov 09, 2023

SELL
$9.9 - $11.56 $117,928 - $137,702
-11,912 Reduced 68.21%
5,552 $55 Million
Q3 2020

Nov 09, 2023

SELL
$8.57 - $12.69 $67,394 - $99,794
-7,864 Reduced 31.05%
17,464 $157 Million
Q2 2020

Nov 09, 2023

BUY
$8.12 - $13.12 $7,916 - $12,792
975 Added 4.0%
25,328 $312 Million
Q4 2019

Nov 09, 2023

BUY
$6.53 - $10.72 $2,435 - $3,998
373 Added 1.56%
24,353 $239 Million
Q3 2019

Nov 09, 2023

BUY
$6.16 - $9.6 $5,353 - $8,342
869 Added 3.76%
23,980 $165 Million
Q2 2019

Nov 09, 2023

SELL
$8.12 - $15.72 $2,841 - $5,502
-350 Reduced 1.49%
23,111 $213 Million
Q1 2019

Nov 09, 2023

SELL
$15.58 - $20.01 $5,094 - $6,543
-327 Reduced 1.37%
23,461 $368 Million
Q4 2018

Nov 09, 2023

SELL
$14.59 - $23.84 $5,836 - $9,536
-400 Reduced 1.65%
23,788 $367 Million
Q3 2018

Nov 09, 2023

BUY
$21.06 - $25.65 $9,097 - $11,080
432 Added 1.82%
24,188 $521 Million
Q1 2018

Nov 09, 2023

SELL
$16.68 - $22.07 $98,378 - $130,168
-5,898 Reduced 19.89%
23,756 $406 Million
Q4 2017

Nov 09, 2023

BUY
$11.23 - $19.1 $56,150 - $95,500
5,000 Added 20.28%
29,654 $562 Million
Q3 2017

Nov 09, 2023

BUY
$15.41 - $32.17 $349,390 - $729,390
22,673
24,654 $434 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.